These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9710224)
1. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Weinheber N; Wolfram M; Harbecke D; Aebischer T Eur J Immunol; 1998 Aug; 28(8):2467-77. PubMed ID: 9710224 [TBL] [Abstract][Full Text] [Related]
2. The role of IL-10 in promoting disease progression in leishmaniasis. Kane MM; Mosser DM J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695 [TBL] [Abstract][Full Text] [Related]
3. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF. Saha B; Saini A; Germond R; Perrin PJ; Harlan DM; Davis TA Eur J Immunol; 1999 Jul; 29(7):2319-29. PubMed ID: 10427995 [TBL] [Abstract][Full Text] [Related]
5. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages. Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349 [TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. Padigel UM; Alexander J; Farrell JP J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669 [TBL] [Abstract][Full Text] [Related]
7. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription. Ricardo-Carter C; Favila M; Polando RE; Cotton RN; Bogard Horner K; Condon D; Ballhorn W; Whitcomb JP; Yadav M; Geister RL; Schorey JS; McDowell MA Parasite Immunol; 2013 Dec; 35(12):409-20. PubMed ID: 23834512 [TBL] [Abstract][Full Text] [Related]
8. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity. Heinzel FP; Rerko RM; Hujer AM Cell Immunol; 1998 Mar; 184(2):129-42. PubMed ID: 9630839 [TBL] [Abstract][Full Text] [Related]
9. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. Jones DE; Buxbaum LU; Scott P J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. Alleva DG; Kaser SB; Beller DI J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720 [TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40. Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810 [TBL] [Abstract][Full Text] [Related]
12. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Qi H; Ji J; Wanasen N; Soong L Infect Immun; 2004 Feb; 72(2):988-95. PubMed ID: 14742545 [TBL] [Abstract][Full Text] [Related]
13. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074 [TBL] [Abstract][Full Text] [Related]
14. The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation. Padigel UM; Perrin PJ; Farrell JP J Immunol; 2001 Nov; 167(10):5874-9. PubMed ID: 11698463 [TBL] [Abstract][Full Text] [Related]
15. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA. von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504 [TBL] [Abstract][Full Text] [Related]
17. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity. Buxbaum LU; Denise H; Coombs GH; Alexander J; Mottram JC; Scott P J Immunol; 2003 Oct; 171(7):3711-7. PubMed ID: 14500670 [TBL] [Abstract][Full Text] [Related]
18. Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-gamma but not IL-4 is associated with the development of cutaneous lesions. Guevara-Mendoza O; Une C; Franceschi Carreira P; Orn A Scand J Immunol; 1997 Jul; 46(1):35-40. PubMed ID: 9246206 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Buxbaum LU; Scott P Infect Immun; 2005 Apr; 73(4):2101-8. PubMed ID: 15784551 [TBL] [Abstract][Full Text] [Related]
20. Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice. Aguilar Torrentera F; Laman JD; Van Meurs M; Adorini L; Muraille E; Carlier Y Infect Immun; 2002 Sep; 70(9):5075-80. PubMed ID: 12183555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]